Fulminant Type 1 Diabetes Mellitus after SARS-CoV-2 Vaccination: A Case Report

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have been used worldwide to control the coronavirus disease pandemic. However, several adverse effects have been reported following vaccination. Therefore, further research on the adverse effects in individuals predisposed to life...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Rong, Lin, Yu-Wei, Chen, Mei-Hsiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692754/
https://www.ncbi.nlm.nih.gov/pubmed/36423001
http://dx.doi.org/10.3390/vaccines10111905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692754/
https://www.ncbi.nlm.nih.gov/pubmed/36423001
http://dx.doi.org/10.3390/vaccines10111905

Ejemplares similares